Stockreport

AZTR: First ATR-12 Patient Screened [Yahoo! Finance]

Azitra Inc  (AZTR) 
PDF Azitra, Inc. (NYSE:AZTR) reported second quarter results following a $10 million raise which enabled the company to begin enrolling its ATR-12 Phase Ib trial for Nether [Read more]